The research group is focused on person-centred, safe and effective use of medicines and public health improvement.
Pharmacoepidemiology
Our aim is to maximise the use of Scotland’s rich health informatics datasets, including the new individual level prescribing dataset, to support stratified medicine approaches and investigate the impact of interventions on public health.
The programme focuses on:
- medicine adherence
- clinical outcomes
- toxicities in real world clinical practice
We lead the Farr Institute pharmacoepidemiology programme. This focuses on cardiovascular and immunological therapies and have complementary programmes in respiratory disease, cancer and infection.
We also lead the clinical infection informatics work stream within the new Scottish Healthcare Associated Infection Prevention Institute. Our clinical–academic pharmacoepidemiology network is embedded in local NHS systems and links with other international research networks.
Practice research
Our aim is to maximise health outcomes and reduce resource wastage through the design and testing of new health care intervention models.
The programme focuses on:
- new health technologies (medicines, diagnostics, telehealth, robotics)
- dosage guidelines to optimise therapy
- service delivery models
Funding
Current funding includes:
- Macmillan Cancer Support to explore new pharmacy palliative care service models in urban and rural communities
- Scottish Government/NHS Boards to develop and evaluate the adoption of clinical guidelines and to evaluate robotic technologies in pharmacy
- Health Foundation to lead the evaluation of the new Scottish Patient Safety Programme – Pharmacy in Primary Care Programme
Our experts
Academics
- Marion Bennie
- Gazala Akram
- Phillipe Autier
- Marie Boyd
- Anne Boyter
- Harry Burns
- Pierre Hainaut
- Alex Mullen
- Alison Thomson
- Moira Kinnear
- Jenny McDonald
- Scott Bryson
Research staff
- Samantha Alvarez-Madrazo
- Emma Dunlop Corcoran
- Rosemary Newham